Early Phase 3 data on retatrutide (triple agonist) shows pronounced appetite suppression beginning as early as week 2-4, with some patients reporting more complete food noise elimination than with semaglutide alone
2
Ive had to focus on properly fuelling myself
de Mello AH, Schraiber RB, Goldim MPS, Garcez ML, Gomes ML, de Bem Silveira G, Zaccaron RP, Schuck PF, Budni J, Silveira PCL, Petronilho F, Rezin GT (2019) Omega-3 fatty acids attenuate brain alterations in High-Fat Diet-Induced obesity model
Providers should approach GLP-1 therapy the way they approach antihypertensives or statins: as long-term tools for a chronic condition, with discontinuation decisions made based on clinical indication rather than an arbitrary treatment timeline